Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Methods and compositions for the attenuation and/or prevention of stress/catabolic responses

a catabolic response and metabolic stress technology, applied in the field of metabolic stress attenuation and/or catabolic response attenuation and/or catabolic response, compositions and methods for managing or preventing catabolic stress, can solve the problems of few therapeutic options for treating such conditions, inability to overcome physiological effects, significant influence on morbidity and mortality, etc., to prevent or at least reduce the risk of metabolic stress, the effect of attenuating metabolic stress and/or cataboli

Inactive Publication Date: 2005-07-21
PHARMANUTRIENTS
View PDF9 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0010] To this end, the present invention provides a method for preventing or minimizing the onset of metabolic stress in an individual that may be susceptible to same, comprising the step of administering a therapeutically effective amount of a composition including conjugated linoleic acid.

Problems solved by technology

Although such metabolic stress is known and has been demonstrated, there are few therapeutic options for treating such conditions.
As a result, over a period of time, individuals remain in a persistent catabolic state, unable to overcome the physiological effects of these catabolic agents.
In this regard, due to illness, such as cancer or chronic immune disorders, metabolic stress can be induced that results in cachexia.
While most patients exhibit favorable results for up to 60 days following such a procedure, evidence suggests the existence of a delayed stress response which may significantly influence morbidity and mortality following cardiac bypass surgery.
It is believed that although there is a moderate symptomatic suppression of the stress response through the use of steroids, this treatment can be accompanied by significant side effects and long-term consequences.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

example no.1

EXAMPLE NO. 1

[0053] In order to treat stress-catabolic response sufficient product will be administered so that the patient receives 500 mg to 10,000 mg of conjugated linoleic acid per day. It is believed that this level of conjugated linoleic acid will at least reduce the effects of metabolic stress.

example no.2

EXAMPLE NO. 2

[0054] In order to treat cachexia associated with chronic illness, sufficient product would be administered to provide 500 mg to about 10,000 mg of conjugated linoleic acid per day. It is believed that at such levels the cachexia should be at least reduced.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Timeaaaaaaaaaa
Massaaaaaaaaaa
Mass flow rateaaaaaaaaaa
Login to View More

Abstract

Methods and compositions for treating metabolic stress are provided. The method comprises the steps of administering a therapeutically effective amount of conjugated linoleic acid.

Description

BACKGROUND OF THE INVENTION [0001] The present invention relates generally to compositions and methods for the treatment of disease states. More specifically, the present invention relates to compositions and methods for managing or preventing catabolic stress. [0002] Many diseases are known to be associated with metabolic stress condition. These acute or chronic illnesses can either initiate and / or maintain a metabolic stress condition. The metabolic stress condition has been demonstrated clinically through such events as adverse response to trauma, obesity, cancer, transfusions, acute and chronic diseases, various types of surgery, immunological disorders, and infections. [0003] Although such metabolic stress is known and has been demonstrated, there are few therapeutic options for treating such conditions. As a result, over a period of time, individuals remain in a persistent catabolic state, unable to overcome the physiological effects of these catabolic agents. [0004] An exampl...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/20
CPCA61K31/20
Inventor MENARD, MICHAELROCKWAY, SUSIE
Owner PHARMANUTRIENTS
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products